AHMEDABAD, India, Nov. 6, 2025 /PRNewswire/ -- MiCoB Private Limited, a pioneer in sustainable and rapid 3D Concrete Printing (3DCP) technology,…
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…